Literature DB >> 17664265

Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.

Jan Andersson1, Arina Samarina, Joshua Fink, Sayma Rahman, Susanna Grundström.   

Abstract

Protective immunity in tuberculosis is dependent on the coordinated release of cytolytic effector molecules from effector T cells and the subsequent granule-associated killing of infected target cells. In this study, we investigated the expression of cytolytic (perforin and granzyme A) and antimicrobial (granulysin) molecules at the single-cell level in cryopreserved lung tissue from patients with chronic, progressive tuberculosis disease. Quantification of protein-expressing cells was performed by in situ imaging, while mRNA levels in the infected tissue were analyzed by real-time PCR. Persistent inflammation, including excessive expression of inducible nitric oxide synthase in CD68+ macrophages and significant infiltration of CD3+, CD8+ and CD4+ T cells, was evident in tuberculosis lesions in all patients. However, despite the accumulation of CD3+ T cells, perforin- and granulysin-expressing CD3+ T cells were detected at two- to threefold-lower ratios in the tuberculosis lesions than in distal lung parenchyma and uninfected control lungs, respectively. This was evident at both the protein and mRNA levels. Moreover, perforin- and granulysin-expressing CD8+ T cells were scarce in individual granulomas within the tuberculosis lesions. In contrast, significant up-regulation of granzyme A-expressing CD3+ T cells was evident in the lesions from all patients. Confocal microscopy revealed coexpression of perforin and granulysin, primarily in CD8+ T cells; however, this expression was lower in the tuberculosis lesions. These findings suggest that symptomatic, chronic tuberculosis disease is associated with insufficient up-regulation of perforin and granulysin coexpression in CD8+ T cells at the local site of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664265      PMCID: PMC2168267          DOI: 10.1128/IAI.00624-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  75 in total

1.  Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology.

Authors:  V E Watson; L L Hill; L B Owen-Schaub; D W Davis; D J McConkey; C Jagannath; R L Hunter; J K Actor
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 2.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.

Authors:  A M Dannenberg
Journal:  Immunol Today       Date:  1991-07

3.  Mycobacteria-reactive Lyt-2+ T cell lines.

Authors:  G De Libero; I Flesch; S H Kaufmann
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

4.  Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.

Authors:  I Müller; S P Cobbold; H Waldmann; S H Kaufmann
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

5.  Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice.

Authors:  L Kremer; J Estaquier; I Wolowczuk; F Biet; J C Ameisen; C Locht
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis.

Authors:  C L Silva; D B Lowrie
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Granulysin, a T cell product, kills bacteria by altering membrane permeability.

Authors:  W A Ernst; S Thoma-Uszynski; R Teitelbaum; C Ko; D A Hanson; C Clayberger; A M Krensky; M Leippe; B R Bloom; T Ganz; R L Modlin
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages.

Authors:  N V Serbina; C C Liu; C A Scanga; J L Flynn
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

Authors:  A O Sousa; R J Mazzaccaro; R G Russell; F K Lee; O C Turner; S Hong; L Van Kaer; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2.

Authors:  C A Scanga; V P Mohan; K Yu; H Joseph; K Tanaka; J Chan; J L Flynn
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  40 in total

1.  Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis.

Authors:  J Ma; J Lu; H Huang; X Teng; M Tian; Q Yu; X Yuan; Y Jing; C Shi; J Li; X Fan
Journal:  Gene Ther       Date:  2015-07-16       Impact factor: 5.250

2.  Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.

Authors:  Ajay Grover; Amber Troy; Jenny Rowe; JoLynn M Troudt; Elizabeth Creissen; Jennifer McLean; Prabal Banerjee; Gerold Feuer; Angelo A Izzo
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

3.  Pleural mesothelial cells promote expansion of IL-17-producing CD8+ T cells in tuberculous pleural effusion.

Authors:  X Li; Q Zhou; W B Yang; X Z Xiong; R H Du; J C Zhang
Journal:  J Clin Immunol       Date:  2013-01-09       Impact factor: 8.317

4.  Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Parakkal Jovvian George; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

Review 5.  Granulysin: killer lymphocyte safeguard against microbes.

Authors:  Farokh Dotiwala; Judy Lieberman
Journal:  Curr Opin Immunol       Date:  2019-05-18       Impact factor: 7.486

6.  Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Authors:  Sayma Rahman; Isabelle Magalhaes; Jubayer Rahman; Raija K Ahmed; Donata R Sizemore; Charles A Scanga; Frank Weichold; Frank Verreck; Ivanela Kondova; Jerry Sadoff; Rigmor Thorstensson; Mats Spångberg; Mattias Svensson; Jan Andersson; Markus Maeurer; Susanna Brighenti
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

Review 8.  CD8 T cells and Mycobacterium tuberculosis infection.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  Semin Immunopathol       Date:  2015-04-28       Impact factor: 9.623

9.  Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Authors:  Joshua S Woodworth; Ying Wu; Samuel M Behar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 10.  Susceptibility to infectious diseases based on antimicrobial peptide production.

Authors:  Bruno Rivas-Santiago; Carmen J Serrano; J Antonio Enciso-Moreno
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.